| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K/A | 10-K | 10-K/A |
| Revenues: |
| United States of America | 198.4 | 216.6 | 232.8 | 211.9 | 126.0 | | 43.3 | 1.8 |
| Healthcare | 181.0 | 192.9 | 217.4 | 209.9 | 130.3 | | | |
| Software and other | 71.1 | 78.6 | 94.5 | 80.9 | 42.4 | 33.0 | 27.6 | 29.6 |
| DNA | 31.3 | 38.8 | 31.5 | 22.5 | 10.0 | | | |
| Other | | | | | | 33.8 | | 28.2 |
| Total revenues [+] | 212.3 | 231.7 | 248.9 | 232.4 | 140.3 | 66.8 | 56.7 | 59.6 |
| Products | 71.1 | 78.6 | 94.5 | 80.9 | 42.4 | | | |
| License and maintenance | 103.2 | 109.3 | 113.5 | 109.6 | 74.7 | | | |
| Technology services | 38.0 | 43.8 | 41.0 | 41.9 | 23.2 | | | |
| Revenue growth [+] | -8.4% | -6.9% | 7.1% | 65.6% | 109.9% | 17.8% | -4.8% | -19.8% |
| United States of America | -8.4% | -7.0% | 9.9% | 68.2% | | | 2357.7% | -42.1% |
| Healthcare | -6.2% | -11.3% | 3.5% | 61.1% | | | | |
| Software and other | -9.5% | -16.8% | 16.7% | 90.8% | 28.4% | 19.9% | -6.9% | -26.5% |
| DNA | -19.2% | 23.1% | 40.2% | 124.1% | | | | |
| Europe | 1.0% | -12.9% | -0.9% | 13.4% | | | 43175.0% | -92.8% |
| Cost of goods sold [+] | 143.6 | 157.0 | 163.8 | 138.9 | 104.4 | 19.4 | 20.1 | 29.3 |
| Cost of product sales | 30.4 | 41.8 | 43.3 | 29.1 | 13.8 | | | |
| Cost of licenses/maintenance agreements | 27.7 | 29.0 | 31.1 | 29.1 | 24.4 | | | |
| Cost of technology services | 25.1 | 25.1 | 24.7 | 21.1 | 15.4 | | | |
| Gross profit | 68.7 | 74.7 | 85.1 | 93.6 | 35.9 | 47.5 | 36.7 | 30.2 |
| Gross margin | 32.4% | 32.2% | 34.2% | 40.2% | 25.6% | 71.0% | 64.6% | 50.7% |
| Selling, general and administrative [+] | 59.1 | 71.3 | 86.3 | 71.4 | 105.5 | 22.2 | 29.8 | 48.1 |
| Sales and marketing | 32.0 | 36.6 | 43.9 | 38.8 | 20.7 | 9.2 | 9.3 | 18.6 |
| General and administrative | 27.1 | 34.7 | 42.4 | 32.6 | 22.0 | 13.0 | 20.5 | 29.5 |
| Other selling, general and administrative | | | | | 62.8 | | | |
| Research and development | 28.4 | 32.4 | 32.4 | 27.5 | 20.1 | 10.7 | 13.2 | 21.1 |
| Other operating expenses | -52.8 | -54.1 | -55.8 | -50.2 | -102.6 | 2.8 | 15.3 | 132.3 |
| EBITDA [+] | 48.9 | 39.1 | 40.1 | 63.5 | 34.9 | 17.9 | -14.9 | -154.5 |
| EBITDA growth | 25.3% | -2.7% | -36.8% | 81.8% | 95.3% | -220.2% | -90.4% | |
| EBITDA margin | 23.1% | 16.9% | 16.1% | 27.3% | 24.9% | 26.8% | -26.2% | -259.3% |
| Depreciation and amortization | 25.1 | 24.5 | 29.3 | 31.5 | 28.8 | 6.1 | 6.8 | 16.7 |
| EBIT [+] | 23.9 | 14.6 | 10.9 | 32.0 | 6.2 | 11.8 | -21.7 | -171.2 |
| EBIT growth | 63.8% | 34.3% | -66.1% | 419.6% | -47.8% | -154.4% | -87.3% | -32.1% |
| EBIT margin | 11.2% | 6.3% | 4.4% | 13.8% | 4.4% | 17.7% | -38.2% | -287.4% |
| Non-recurring items | 0.2 | 4.8 | 4.2 | 2.8 | 14.7 | 2.8 | | |
| Interest expense, net [+] | 17.2 | 21.2 | 32.2 | 28.9 | 17.2 | 2.7 | 1.5 | -1.1 |
| Interest expense | 17.2 | 21.8 | 32.9 | 29.4 | 17.2 | 2.7 | 1.8 | 0.1 |
| Interest income | 0.0 | 0.5 | 0.8 | 0.5 | 0.1 | 0.1 | 0.3 | 1.2 |
| Other income (expense), net [+] | -4.6 | -24.7 | 0.8 | -2.1 | 0.5 | -6.1 | -0.6 | -1.7 |
| Gain (loss) on debt retirement | -4.8 | -23.8 | | | | | | |
| Other | 0.3 | -0.8 | 0.8 | -2.1 | 0.5 | | | |
| Pre-tax income | 1.9 | -36.1 | -24.7 | -1.9 | -25.2 | 0.2 | -23.7 | -171.8 |
| Income taxes | 2.3 | 2.9 | 4.1 | 3.7 | -13.6 | -0.1 | -0.1 | -0.2 |
| Tax rate | 121.6% | | | | 54.2% | | 0.3% | 0.1% |
| Minority interest | 0.0 | 0.0 | 0.0 | 0.0 | | | | |
| Earnings from continuing ops | -0.4 | -39.0 | -28.8 | -8.7 | -30.6 | 0.3 | -23.7 | -171.6 |
| Earnings from discontinued ops | | | | | | 0.3 | | |
| Net income | -0.4 | -39.0 | -28.8 | -8.7 | -30.6 | 0.3 | -23.7 | -171.6 |
| Net margin | -0.2% | -16.8% | -11.6% | -3.7% | -21.8% | 0.4% | -41.7% | -288.0% |
| |
| Basic EPS [+] | $0.00 | ($0.42) | ($0.31) | ($0.10) | ($0.38) | $0.00 | ($0.51) | ($5.06) |
| Growth | -98.9% | 33.0% | 212.3% | -73.7% | -8249.1% | -100.9% | -90.0% | -34.2% |
| Diluted EPS [+] | $0.00 | ($0.42) | ($0.31) | ($0.10) | ($0.38) | $0.00 | ($0.51) | ($5.06) |
| Growth | -98.9% | 33.0% | 212.3% | -73.7% | -8493.6% | -100.9% | -90.0% | -34.2% |
| |
| |
| Shares outstanding (basic) [+] | 95.4 | 93.7 | 92.1 | 86.6 | 80.2 | 60.9 | 46.7 | 33.9 |
| Growth | 1.8% | 1.7% | 6.3% | 8.0% | 31.7% | 30.4% | 37.8% | 0.6% |
| Shares outstanding (diluted) [+] | 95.4 | 93.7 | 92.1 | 86.6 | 80.2 | 62.7 | 46.7 | 33.9 |
| Growth | 1.8% | 1.7% | 6.3% | 8.0% | 27.9% | 34.3% | 37.8% | 0.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |